Connect with us

Technology

BioVid Launches Tumor Worlds™: A Strategic Intelligence System to Decode the Behavioral Logic of Oncology Markets

Published

on

BRISTOL, Pa., Aug. 27, 2026 /PRNewswire/ — BioVid, a leading life science consultancy, today announced the launch of Tumor Worlds™, a proprietary strategic intelligence system that helps pharmaceutical companies anticipate how oncology markets respond to new evidence. Integrating oncology expertise, behavioral science, and BioVid’s proprietary CIAIRA™ AI platform, Tumor Worlds™ moves beyond descriptive market research to provide an early signal model of physician decision-making. The launch begins with Non-Small Cell Lung Cancer (NSCLC), with Prostate and Pancreatic Cancer to follow, and full portfolio expansion planned through 2026. 

BioVid’s Tumor Worlds™ helps pharma companies anticipate how oncology markets respond to new evidence.

To learn more, visit www.biovid.com/tumorworlds.

Clinical evidence now moves faster than most markets can absorb, and one-size-fits-all launch playbooks weren’t built for that pace. Tumor Worlds™ maps the “gravitational forces” of each oncology market, identifying the structural conditions that govern how new evidence is adopted in clinical practice.

“The industry is trapped in a ‘rearview mirror’ approach, relying on historical data to predict what physicians will do next,” said Peggy Hirtle, CEO of BioVid. “We’ve mapped the sociotechnical forces — social norms, institutional constraints, cognitive heuristics — that drive physician behavior, so clients can anticipate where market change will accelerate, stall, or fail before it appears in prescription data.”

“Success in oncology is no longer just about having the best data; it’s about understanding the social and structural reality of the physician,” said Meredith Jacobetz, PhD, Senior Director, Oncology Center of Excellence at BioVid. “Tumor Worlds™ lets us build an actionable picture of the world an asset inhabits before that reality shows up in the data.”

Tumor Worlds™ includes four core suites, powered by a sociotechnical engine mapping behavioral rules across 30+ tumor types:

World Dynamics Suite: Maps the clinical and competitive landscape shaping how fast a market can move.

Treater Insights Suite: Maps physician roles and influence networks, from awareness to prescribing.

Cognitive Insights Suite: Surfaces the psychological drivers behind physician decisions and where messaging fails.

Lifecycle Intelligence Suite: Calibrates risk flags, competitive playbook, and resource allocation across an asset’s life.

CIAIRA™: BioVid’s proprietary AI engine synthesizes data across all four suites to identify leading indicators of physician sentiment as the market evolves.

About BioVid

BioVid is a life science consultancy applying behavioral science and AI to commercial and market access strategy, marrying market opportunity with behavioral insight for clients.

Visit www.biovid.com to learn more. 

Media Contact:

Lynn Clement, Executive Director, Growth Strategy, BioVid

lclement@biovid.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biovid-launches-tumor-worlds-a-strategic-intelligence-system-to-decode-the-behavioral-logic-of-oncology-markets-302861963.html

SOURCE BioVid

Continue Reading

Technology

Allooloo Tops 100M Capital Markets AI Agent Traffic a Month

Published

on

By

Agentic datasets on every listed company in 34 countries: sourced, dated and signed.

VANCOUVER, BC and LONDON, Nov. 20, 2026 /PRNewswire/ — Allooloo Technologies Corp. (Allooloo), maker of agentic datasets for capital markets artificial intelligence (AI) agents, today reported 100M AI agent traffic a month. That is 39 calls a second, 3.4 million a day, across getissuer.ai and Issuerwire.ai, running on 24 Microsoft Azure hyperscale locations globally with always-on Amazon Web Services (AWS) redundancy.

The Data Readiness Gap

Investment banks are not short of AI models. They are short of data an AI agent can use. In a 2026 Teradata study, 77% of technology leaders said 20% or less of their enterprise data is ready for AI agents. Banks are closing that gap on the data they hold, with one governed way in and the source, the date and the owner on every record.

The data a bank does not hold is the other half. An AI agent working on a security needs the issuer, its disclosures and whether it may be ordered, in every market the bank trades. Allooloo delivers that half agent-ready: 41.9K listed companies in 34 countries, a source and a date on every field, and a signed receipt for every read, over Model Context Protocol (MCP).

Two Products

Know Your Product (KYP) is the duty to know a security before it is recommended or sold. Allooloo KYP, at getissuer.ai, answers it for the AI agent: who the issuer is, whether it may be ordered, and who it is for. It covers 41.9K listed companies on 79 exchanges in 34 countries.

Issuerwire.ai is the dated disclosure wire: 3.1 million dated disclosures across 34 countries, each with its source.

Who it matters to:

Investment bank or dealer: its AI agents can show where each fact came from.The issuer: every AI agent reads the same answer about it.Compliance: a signed receipt for every cleared read.

A Signed Receipt for Every Read

Every cleared read on Allooloo leaves a signed receipt, the Record of Cleared Orders (RCO): what was read, when, and under which market’s rules.

Each Market in Its Own Country

Each market is kept in its own country or region, across 24 Microsoft Azure regions, on one MCP server per market. A second copy of every market is made each night on AWS and locked against deletion for 365 days. Allooloo is a Microsoft AI Cloud Partner.

Around the Clock

The products are made around the clock by Allooloo’s own team and AI agents, on the Allooloo Algo. AI agents call them around the clock and pay per call, with no seat and no licence.

“Today we are announcing a milestone: 100M AI agent traffic a month,” said Matthew Keddy, Chief Executive Officer of Allooloo Technologies Corp. “These are the AI agents of capital markets participants, and they want crisp data, five years deep, on 41.9K listed companies across 79 exchanges: sourced, dated and signed. Gain the edge with us.”

In Session and Enterprise Grade

Allooloo is sold two ways. In session, an AI agent calls Allooloo mid-task and pays as it goes (PayGo) on x402, the open payment standard for AI agents, with no seat and no licence. At enterprise grade, a firm licenses the datasets to design, build and run its own AI agents.

About Allooloo Technologies Corp.

Allooloo Technologies Corp. makes agentic capital markets data products for the AI agents of banks, dealers and issuers. Its products, getissuer.ai and Issuerwire.ai, cover 41.9K listed companies on 79 exchanges in 34 countries, kept across 24 Microsoft Azure regions with on-the-fly redundancy on Amazon Web Services (AWS). The result is always-on agentic datasets: in session for AI lab users, and enterprise grade for customers who design, build and run their own AI agents. Allooloo is headquartered in Vancouver, Canada. Please visit: allooloo.ai 

View original content:https://www.prnewswire.com/news-releases/allooloo-tops-100m-capital-markets-ai-agent-traffic-a-month-302947422.html

SOURCE Allooloo Technologies Corp.

Continue Reading

Technology

Allooloo Tops 100M Capital Markets AI Agent Traffic a Month

Published

on

By

Agentic datasets on every listed company in 34 countries: sourced, dated and signed.

VANCOUVER, BC and LONDON, Nov. 21, 2026 /PRNewswire/ — Allooloo Technologies Corp. (Allooloo), maker of agentic datasets for capital markets artificial intelligence (AI) agents, today reported 100M AI agent traffic a month. That is 39 calls a second, 3.4 million a day, across getissuer.ai and Issuerwire.ai, running on 24 Microsoft Azure hyperscale locations globally with always-on Amazon Web Services (AWS) redundancy.

The Data Readiness Gap

Investment banks are not short of AI models. They are short of data an AI agent can use. In a 2026 Teradata study, 77% of technology leaders said 20% or less of their enterprise data is ready for AI agents. Banks are closing that gap on the data they hold, with one governed way in and the source, the date and the owner on every record.

The data a bank does not hold is the other half. An AI agent working on a security needs the issuer, its disclosures and whether it may be ordered, in every market the bank trades. Allooloo delivers that half agent-ready: 41.9K listed companies in 34 countries, a source and a date on every field, and a signed receipt for every read, over Model Context Protocol (MCP).

Two Products

Know Your Product (KYP) is the duty to know a security before it is recommended or sold. Allooloo KYP, at getissuer.ai, answers it for the AI agent: who the issuer is, whether it may be ordered, and who it is for. It covers 41.9K listed companies on 79 exchanges in 34 countries.

Issuerwire.ai is the dated disclosure wire: 3.1 million dated disclosures across 34 countries, each with its source.

Who it matters to:

Investment bank or dealer: its AI agents can show where each fact came from.The issuer: every AI agent reads the same answer about it.Compliance: a signed receipt for every cleared read.

A Signed Receipt for Every Read

Every cleared read on Allooloo leaves a signed receipt, the Record of Cleared Orders (RCO): what was read, when, and under which market’s rules.

Each Market in Its Own Country

Each market is kept in its own country or region, across 24 Microsoft Azure regions, on one MCP server per market. A second copy of every market is made each night on AWS and locked against deletion for 365 days. Allooloo is a Microsoft AI Cloud Partner.

Around the Clock

The products are made around the clock by Allooloo’s own team and AI agents, on the Allooloo Algo. AI agents call them around the clock and pay per call, with no seat and no licence.

“Today we are announcing a milestone: 100M AI agent traffic a month,” said Matthew Keddy, Chief Executive Officer of Allooloo Technologies Corp. “These are the AI agents of capital markets participants, and they want crisp data, five years deep, on 41.9K listed companies across 79 exchanges: sourced, dated and signed. Gain the edge with us.”

In Session and Enterprise Grade

Allooloo is sold two ways. In session, an AI agent calls Allooloo mid-task and pays as it goes (PayGo) on x402, the open payment standard for AI agents, with no seat and no licence. At enterprise grade, a firm licenses the datasets to design, build and run its own AI agents.

About Allooloo Technologies Corp.

Allooloo Technologies Corp. makes agentic capital markets data products for the AI agents of banks, dealers and issuers. Its products, getissuer.ai and Issuerwire.ai, cover 41.9K listed companies on 79 exchanges in 34 countries, kept across 24 Microsoft Azure regions with on-the-fly redundancy on Amazon Web Services (AWS). The result is always-on agentic datasets: in session for AI lab users, and enterprise grade for customers who design, build and run their own AI agents. Allooloo is headquartered in Vancouver, Canada. Please visit: allooloo.ai 

Contact: Matthew Keddy, CEO. mk@allooloo.ai +1 647 237 7744

View original content:https://www.prnewswire.com/apac/news-releases/allooloo-tops-100m-capital-markets-ai-agent-traffic-a-month-302947427.html

SOURCE Allooloo Technologies Corp.

Continue Reading

Technology

Ziehm-Orthoscan Announces Executive Leadership Transition Following 18 Years of Significant Growth

Published

on

By

Ziehm-Orthoscan Announces CEO Transition and Executive Leadership Appointments

SCOTTSDALE, Ariz., Nov. 20, 2026 /PRNewswire-PRWeb/ — Ziehm-Orthoscan Inc., the leader in mobile C-arm imaging solutions, today announced an executive leadership transition as President and Chief Executive Officer Nelson Mendes prepares to step down on December 31, 2026, following 18 years of distinguished leadership.

Effective January 1, 2027, Travis Prikryl will assume the role of Chief Executive Officer, and Hogie Saunders will be appointed Chief Operating Officer. Both executives will also serve as Managing Directors of Ziehm-Orthoscan Inc.

Under Mendes’ leadership, Ziehm-Orthoscan experienced extraordinary growth and transformation, evolving from a small U.S. operation into a major contributor to the company’s global business. Since 2009, U.S. operations have grown from approximately six employees to nearly 200, reflecting Ziehm-Orthoscan’s significant expansion and continued investment. This growth includes the establishment of a new headquarters and production facility in Scottsdale, Arizona, which serves as the global center for the development and manufacturing of all Orthoscan mini C-arm systems.

A significant milestone in this transformation was the acquisition and integration of Orthoscan in 2015, bringing together Ziehm’s full-size mobile C-arm technology and Orthoscan’s mini C-arm expertise. This strategic expansion established a comprehensive mobile imaging portfolio, strengthened the company’s competitive position, and accelerated its growth throughout the U.S. healthcare market.

Throughout his tenure, Mendes championed innovation, operational excellence, and customer relationships, helping establish Ziehm-Orthoscan as a trusted imaging partner to healthcare institutions nationwide.

To ensure a seamless transition, Mendes will remain with the company as a full-time strategic advisor through March 31, 2027, followed by a part-time consulting role supporting the organization’s continued development.

The appointments of Travis Prikryl and Hogie Saunders represent the next chapter in Ziehm-Orthoscan’s long-term growth strategy. Together with the company’s experienced management team, they will focus on advancing imaging innovation, strengthening customer partnerships, expanding market opportunities, and building on the strong foundation established over the past 18 years.

Ziehm-Orthoscan extends its sincere appreciation to Nelson Mendes for his exceptional leadership and contributions while expressing full confidence in the incoming executive team to guide the organization into its next phase of growth and success.

About Ziehm-Orthoscan

Ziehm-Orthoscan is the leader of innovative mobile imaging solutions, combining Ziehm’s expertise in full-size mobile C-arms with Orthoscan’s specialized mini C-arm technology. The company is committed to advancing medical imaging through innovation, exceptional service, and solutions designed to meet the evolving needs of healthcare professionals.

Media Contact

Rich Shaul, Vice President Marketing, Ziehm-Orthoscan, Inc., 1 4805038010, marketing@ziehm-orthoscan.com, https://ziehm-orthoscan.com/

View original content to download multimedia:https://www.prweb.com/releases/ziehm-orthoscan-announces-executive-leadership-transition-following-18-years-of-significant-growth-302946604.html

SOURCE Ziehm-Orthoscan, Inc.

Continue Reading

Trending